Skip to main content
. 2020 Jun 24;19:1533033820930335. doi: 10.1177/1533033820930335

Table 1.

Characteristics of Patients.

Clinical data No. (%) or median (range) Clinical data No. (%) or median (range)
Age, years 48 (34-75) TNM stage
Sex  III 12 (37.5)
 Male 24 (75.0)  IV 20 (62.5)
 Female 8 (25.0) KPS score
Histologic type  ≥80 22 (68.8)
 SCC 29 (90.6)  <80 10 (31.2)
 Adenocarcinoma 2 (6.3) Previous treatment
 Undifferentiated 1 (3.1)  Surgery 8 (25.0)
Location   Radical rsct 6 (18.8)
 Cervical 6 (18.8)   Palliative rsct 2 (6.3)
 Thoracic (upper) 9 (28.1)  Radiotherapy 20 (62.5)
 Thoracic (middle) 11 (34.4)   PORT 6 (18.8)
 Thoracic (lower) 6 (18.8)   Definitive RT 10 (31.3)
Length(cm)   Palliative RT 4 (12.5)
 ≤4 10 (31.2) Chemotherapy 17 (53.1)
 >4, ≤6 16 (50.0)  Induction 2 (6.3)
 >6 6 (18.8)  Concurrent 6 (18.8)
Presenting symptoms  Adjuvant 9 (28.1)
 Dysphagia 32 (100) PDT cycle
 Pain 15 (46.9)  1 27 (84.4)
 Cough 10 (31.2)  2 4 (12.5)
 Sonar 2 (6.3)  3 1 (3.1)

Abbreviations: KPS, Karnofsky Performance Status; PDT, photodynamic therapy; PORT, postoperative radiotherapy; Rsct, resection; RT, radiotherapy; SCC, squamous cell carcinoma.